Prognostic Value of BNP in MCS - a 25 Year Follow up Study

Recruiting now

Conditions studied: Heart Failure, Left Ventricular Assist Device, Prognosis, Durable Mechanical Support Device

In brief

A biobank has been created to investigate the prognostic value of biomarkers (mainly BNP) in patients implanted with durable mechanical assist devices comparing patients with advanced HF supported by MCS with those who are transplanted and those who remain on optimal medical therapy. Patients will be followed up for 25 years after inclusion.

Key facts

Study ID

NCT04377854

Run by

Rigshospitalet, Denmark

People needed

1000

Starts

2020-09-18

Expected to finish

2045-08-01

Last updated by the study team

2021-05-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients referred for evaluation for advanced HF treatment at the Rigshospital in Denmark
• Age>18 years

You may not qualify if…

• No consent

Where it is running

• Rigshospitalet — Copenhagen, DK, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.